Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: Position paper from the Italian Task Force for Cutaneous Lymphomas

V. Grandi, P. Fava, S. Rupoli, S. Alberti Violetti, L. Canafoglia, P. Quaglino, E. Berti, N. Pimpinelli

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

UV-based (PUVA and narrowband UVB) phototherapy is broadly and commonly used in the treatment of Cutaneous T-cell Lymphomas (CTCL), yet unfortunately, the evidence for the efficacy of these treatments is based only on case series or prospective but non-randomized studies. Therefore, no internationally approved guidelines exist and no standardization of schedules has been proposed. Recently, consensus guidelines have been published by the United States Cutaneous Lymphoma Consortium. The aim of this study was to review the biological and clinical evidences on PUVA and NB-UVB in CTCL and to critically evaluate acceptability and feasibility of these guidelines in the real-life setting from the perspective of the Cutaneous Lymphoma Task Force of the Italian Lymphoma Foundation (Fondazione Italiana Linfomi, FIL).

Original languageEnglish
Pages (from-to)683-691
JournalJournal of the European Academy of Dermatology and Venereology
Volume32
Issue number5
DOIs
Publication statusPublished - 2018

Fingerprint

Mycosis Fungoides
Advisory Committees
Cutaneous T-Cell Lymphoma
Lymphoma
Guidelines
Skin
Phototherapy
Appointments and Schedules
Therapeutics

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

@article{d8b49b54c17f43f39f106377883e7a81,
title = "Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides: Position paper from the Italian Task Force for Cutaneous Lymphomas",
abstract = "UV-based (PUVA and narrowband UVB) phototherapy is broadly and commonly used in the treatment of Cutaneous T-cell Lymphomas (CTCL), yet unfortunately, the evidence for the efficacy of these treatments is based only on case series or prospective but non-randomized studies. Therefore, no internationally approved guidelines exist and no standardization of schedules has been proposed. Recently, consensus guidelines have been published by the United States Cutaneous Lymphoma Consortium. The aim of this study was to review the biological and clinical evidences on PUVA and NB-UVB in CTCL and to critically evaluate acceptability and feasibility of these guidelines in the real-life setting from the perspective of the Cutaneous Lymphoma Task Force of the Italian Lymphoma Foundation (Fondazione Italiana Linfomi, FIL).",
author = "V. Grandi and P. Fava and S. Rupoli and {Alberti Violetti}, S. and L. Canafoglia and P. Quaglino and E. Berti and N. Pimpinelli",
year = "2018",
doi = "10.1111/jdv.14668",
language = "English",
volume = "32",
pages = "683--691",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "wiley",
number = "5",

}

TY - JOUR

T1 - Standardization of regimens in Narrowband UVB and PUVA in early stage mycosis fungoides

T2 - Position paper from the Italian Task Force for Cutaneous Lymphomas

AU - Grandi, V.

AU - Fava, P.

AU - Rupoli, S.

AU - Alberti Violetti, S.

AU - Canafoglia, L.

AU - Quaglino, P.

AU - Berti, E.

AU - Pimpinelli, N.

PY - 2018

Y1 - 2018

N2 - UV-based (PUVA and narrowband UVB) phototherapy is broadly and commonly used in the treatment of Cutaneous T-cell Lymphomas (CTCL), yet unfortunately, the evidence for the efficacy of these treatments is based only on case series or prospective but non-randomized studies. Therefore, no internationally approved guidelines exist and no standardization of schedules has been proposed. Recently, consensus guidelines have been published by the United States Cutaneous Lymphoma Consortium. The aim of this study was to review the biological and clinical evidences on PUVA and NB-UVB in CTCL and to critically evaluate acceptability and feasibility of these guidelines in the real-life setting from the perspective of the Cutaneous Lymphoma Task Force of the Italian Lymphoma Foundation (Fondazione Italiana Linfomi, FIL).

AB - UV-based (PUVA and narrowband UVB) phototherapy is broadly and commonly used in the treatment of Cutaneous T-cell Lymphomas (CTCL), yet unfortunately, the evidence for the efficacy of these treatments is based only on case series or prospective but non-randomized studies. Therefore, no internationally approved guidelines exist and no standardization of schedules has been proposed. Recently, consensus guidelines have been published by the United States Cutaneous Lymphoma Consortium. The aim of this study was to review the biological and clinical evidences on PUVA and NB-UVB in CTCL and to critically evaluate acceptability and feasibility of these guidelines in the real-life setting from the perspective of the Cutaneous Lymphoma Task Force of the Italian Lymphoma Foundation (Fondazione Italiana Linfomi, FIL).

UR - http://www.scopus.com/inward/record.url?scp=85041026687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041026687&partnerID=8YFLogxK

U2 - 10.1111/jdv.14668

DO - 10.1111/jdv.14668

M3 - Article

AN - SCOPUS:85041026687

VL - 32

SP - 683

EP - 691

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 5

ER -